<DOC>
	<DOCNO>NCT00932490</DOCNO>
	<brief_summary>The primary aim study : 1 . Test effectiveness tailor protocol promote adherence oral chemotherapeutic agent adult receive new oral chemotherapeutic agent breast , colorectal , GIST , renal cell , hepatocellular cancer . Exploratory Aims : 2 . Examine adherence oral chemotherapeutic agent time 2 , 4 6 month sample breast , colorectal , GIST , renal cell , HPCC cancers patient . 3 . Examine effect age , gender , caregiver availability , personal involvement health care , depression adherence oral chemotherapeutic agent .</brief_summary>
	<brief_title>Tailored Intervention Protocol Oral Chemotherapy Adherence</brief_title>
	<detailed_description>While cancer patient express preference oral medication , compliance medication varies . Patients successfully adhere chemotherapy regimens great chance non-recurrence long-term quality life . Thus , help patient tolerate oral chemotherapy regimens critical survival . The aim study 1 ) test effectiveness tailor protocol promote adherence oral chemotherapeutic agent adult receive treatment cancer , 2 ) examine adherence oral chemotherapeutic agent time , 3 ) examine effect age , gender , caregiver availability , personal involvement health care , depression adherence rate oral chemotherapeutic agent . The tailored adherence protocol base self-regulatory model adherence . The intervention identify patient knowledge , behavioral skill , affective support tailor adherence strategy overcome barrier three category . A randomized clinical trial examine adherence rate 150 adult start new oral chemotherapeutic agent . A control group receive standard chemotherapy education . Participants experimental group receive standard education , assessment tailor intervention develop advanced practice nurse . The intervention administer via telephone call six month . Patient adherence rate measure group 2 , 4 6 month use self report , symptom profile , pharmacy fill rate . To determine effectiveness adherence protocol , use Generalized Estimating Equations ( SAS ) , provide unified approach longitudinal modeling technique normally non-normally distributed outcome variable .</detailed_description>
	<criteria>diagnosis Breast , Colorectal , GIST , Renal , HPCC , Myeloma Chronic Leukemia 18 year old treatment regimen include least one oral chemotherapeutic agent ability read write English ability give inform consent ability prescription oral chemotherapy fill Duke University Medical Center pharmacy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>